Gossamer Bio
Carolynn Chang is a seasoned professional currently serving as the Senior Director of Market Insights at Gossamer Bio. Prior experience includes significant roles at Gilead Sciences, where Chang served as Director of Commercial Strategic Insights in Oncology and played a pivotal role in launching and growing Trodelvy across various cancer indications. Achievements include spearheading successful marketing campaigns, establishing market research programs for pre-launch products, and earning multiple awards for innovation and excellence. Prior to Gilead, Chang held consulting positions at IQVIA and conducted research at Brigham and Women's Hospital, resulting in published findings on targeted drug delivery mechanisms. Chang holds a Bachelor of Science degree in Biomedical Engineering from Boston University.
This person is not in any teams
This person is not in any offices
Gossamer Bio
1 followers
Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio’s strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with a strong track record of execution in immunology, inflammation, fibrosis and oncology.